PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 257 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,505 | -43.6% | 300 | -10.2% | 0.00% | – |
| Q2 2023 | $4,442 | +27.9% | 334 | +11.3% | 0.00% | – |
| Q1 2023 | $3,474 | -1.7% | 300 | -30.6% | 0.00% | – |
| Q4 2022 | $3,534 | +76.7% | 432 | +24.9% | 0.00% | – |
| Q3 2022 | $2,000 | – | 346 | +652.2% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 46 | -89.5% | 0.00% | -100.0% |
| Q1 2022 | $4,000 | -20.0% | 437 | +85.2% | 0.00% | 0.0% |
| Q4 2021 | $5,000 | -37.5% | 236 | -25.8% | 0.00% | -50.0% |
| Q3 2021 | $8,000 | -33.3% | 318 | -4.8% | 0.00% | -33.3% |
| Q2 2021 | $12,000 | +9.1% | 334 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $11,000 | +22.2% | 334 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $9,000 | +200.0% | 334 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $3,000 | – | 334 | +11033.3% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 3 | -99.0% | 0.00% | -100.0% |
| Q4 2019 | $2,000 | – | 298 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 1,446,459 | $48,182,000 | 7.22% |
| BOURNE LENT ASSET MANAGEMENT INC | 536,800 | $17,881,000 | 5.70% |
| Casdin Capital, LLC | 5,000,000 | $166,550,000 | 4.96% |
| Iron Triangle Partners LP | 935,805 | $31,172,000 | 3.96% |
| Jackson Square Partners, LLC | 12,911,695 | $430,088,000 | 2.44% |
| SB Management Ltd | 9,861,089 | $328,473,000 | 2.12% |
| Abacus Planning Group, Inc. | 180,000 | $5,996,000 | 1.92% |
| BERKSHIRE CAPITAL HOLDINGS INC | 413,800 | $13,784,000 | 1.57% |
| ARK Investment Management | 21,301,191 | $709,543,000 | 1.41% |
| Nikko Asset Management Americas, Inc. | 5,247,237 | $174,785,000 | 0.86% |